Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Current Assets (2021 - 2025)

Universe Pharmaceuticals (UPC) has disclosed Current Assets for 5 consecutive years, with $53.6 billion as the latest value for Q3 2025.

  • Quarterly Current Assets rose 3.81% to $53.6 billion in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $53.6 billion through Sep 2025, up 3.81% year-over-year, with the annual reading at $53.6 billion for FY2025, 3.81% up from the prior year.
  • Current Assets hit $53.6 billion in Q3 2025 for Universe Pharmaceuticals, up from $51.6 billion in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $53.6 billion in Q3 2025 to a low of $25.3 million in Q3 2023.
  • Historically, Current Assets has averaged $21.1 billion across 5 years, with a median of $50.5 million in 2021.
  • Biggest five-year swings in Current Assets: plummeted 39.12% in 2023 and later skyrocketed 204246.6% in 2024.
  • Year by year, Current Assets stood at $50.5 million in 2021, then decreased by 17.78% to $41.5 million in 2022, then tumbled by 39.12% to $25.3 million in 2023, then surged by 204246.6% to $51.6 billion in 2024, then increased by 3.81% to $53.6 billion in 2025.
  • Business Quant data shows Current Assets for UPC at $53.6 billion in Q3 2025, $51.6 billion in Q3 2024, and $25.3 million in Q3 2023.